Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikulaa Parachuri

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Eye (London, England)|April 25, 2020
Pachydrusen: the epidemiology of pachydrusen and its relevance to progression of pachychoroid disease spectrumJay Sheth, Giridhar Anantharaman, Nilesh Kumar, et al.
Eye (London, England)|April 30, 2020
Smartphone based ROP (S-ROP) screening-opportunities and challengesJayaprakash Patil, Laxmi Patil, Nikulaa Parachuri, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 21, 2021
Terms non-exudative and non-neovascular: awaiting entry at the doors of AMD reclassificationAshish Sharma, Nikulaa Parachuri, Nilesh Kumar, et al.
Ocular Immunology and Inflammation|May 20, 2021
Understanding Retinal Vasculitis Associated with Brolucizumab: Complex Pathophysiology or Occam's Razor?Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, et al.
Eye (London, England)|February 19, 2025
Aflibercept 2 mg biosimilars-will they lead the Anti-VEGF biosimilar world globallyAshish Sharma, Se Joon Woo, Christopher Seungkyu Lee, et al.
The British Journal of Ophthalmology|September 27, 2020
Notion of tolerating subretinal fluid in neovascular AMD: understanding the fine print before the injection pauseAshish Sharma, Nikulaa Parachuri, Nilesh Kumar, et al.
Eye (London, England)|January 30, 2021
Vortex vein anastomosis and pachychoroid-an evolving understandingAshish Sharma, Nikulaa Parachuri, Nilesh Kumar, et al.
Ophthalmology. Retina|February 7, 2021
Understanding the Mechanisms of Fluid Development in Age-Related Macular DegenerationAshish Sharma, Nilesh Kumar, Nikulaa Parachuri, et al.
Expert Opinion on Biological Therapy|May 13, 2025
The conundrum of abundance: challenges of having too many biosimilarsAshish Sharma, Carl D Regillo, Luke Nicholson, et al.
Eye (London, England)|February 3, 2021
Brolucizumab-foreseeable workflow in the current scenarioAshish Sharma, Nilesh Kumar, Nikulaa Parachuri, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Eye (London, England)|April 25, 2020
Pachydrusen: the epidemiology of pachydrusen and its relevance to progression of pachychoroid disease spectrumJay Sheth, Giridhar Anantharaman, Nilesh Kumar, et al.
Eye (London, England)|April 30, 2020
Smartphone based ROP (S-ROP) screening-opportunities and challengesJayaprakash Patil, Laxmi Patil, Nikulaa Parachuri, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|March 21, 2021
Terms non-exudative and non-neovascular: awaiting entry at the doors of AMD reclassificationAshish Sharma, Nikulaa Parachuri, Nilesh Kumar, et al.
Ocular Immunology and Inflammation|May 20, 2021
Understanding Retinal Vasculitis Associated with Brolucizumab: Complex Pathophysiology or Occam's Razor?Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, et al.
Eye (London, England)|February 19, 2025
Aflibercept 2 mg biosimilars-will they lead the Anti-VEGF biosimilar world globallyAshish Sharma, Se Joon Woo, Christopher Seungkyu Lee, et al.
The British Journal of Ophthalmology|September 27, 2020
Notion of tolerating subretinal fluid in neovascular AMD: understanding the fine print before the injection pauseAshish Sharma, Nikulaa Parachuri, Nilesh Kumar, et al.
Eye (London, England)|January 30, 2021
Vortex vein anastomosis and pachychoroid-an evolving understandingAshish Sharma, Nikulaa Parachuri, Nilesh Kumar, et al.
Ophthalmology. Retina|February 7, 2021
Understanding the Mechanisms of Fluid Development in Age-Related Macular DegenerationAshish Sharma, Nilesh Kumar, Nikulaa Parachuri, et al.
Expert Opinion on Biological Therapy|May 13, 2025
The conundrum of abundance: challenges of having too many biosimilarsAshish Sharma, Carl D Regillo, Luke Nicholson, et al.
Eye (London, England)|February 3, 2021
Brolucizumab-foreseeable workflow in the current scenarioAshish Sharma, Nilesh Kumar, Nikulaa Parachuri, et al.
Pageof 7